Results 71 to 80 of about 36,777 (220)
Nephrolithiasis: Endocrine evaluation
, 2012 Nephrolithias is a common problem in populations around the world, and contribute significantly to the development of end stage renal disease. It is a matter of debate whether the metabolic factors responsible for renal stone formation are similar or ...
Salam Ranabir +2 more
core +1 more source
Nephrolithiasis in Crohn's disease patients: A review of the literature
, 2022 Crohn’s disease is a complex chronic inflammatory disease of the digestive tract. Crohn’s disease presents with extraintestinal complications, such as nephrolithiasis.
Matthew Brockway +4 more
core +1 more source
Clinical Insights Into Hypercalcemia of Malignancy in Childhood
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley +1 more source
The Genetics of Nephrolithiasis [PDF]
Nephron Experimental Nephrology, 2008 Renal stone formation (nephrolithiasis) is a worldwide problem causing substantial morbidity and economic burden. The heritability of stone formation has long been recognized, and with the advent of the genomic era, we have the potential to define the underlying genetic defects.
openaire +2 more sources
Hepatic Glycogen Storage Diseases in Brazil: A Multicenter Study
American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1591-1600, July 2026.ABSTRACT To describe clinical and laboratory characteristics, emphasizing the evolution of patients with hepatic glycogen storage diseases (GSDs) followed in Brazilian reference centers. Multicenter, retrospective study involving 13 centers, using RedCap platform. 132 patients were included: 63 (47.8%) GSD type I (56 Ia, 7 Ib), 13 (9.8%) with type III (
Mariana Pena Costa +23 more
wiley +1 more source
Chemotherapy in nephrolithiasis.
Israel journal of medical sciences, 1971 Isr J Med ...
Timmermann, A., Kallistratos, G.
openaire +3 more sources
Nephrolithiasis in patients with inflammatory bowel disease in the community
, 2013 Dídia Bismara Cury,1,2 Alan C Moss,2 Nestor Schor3 1Scope Clinic, Campo Grande, Brazil; 2Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 3Division of Nephrology, Federal ...
Cury DB, Moss AC, Schor N
core
Head &Neck, Volume 48, Issue 7, Page 1865-1875, July 2026.ABSTRACT Background Parathyroidectomy is the treatment for primary hyperparathyroidism, yet postoperative hypocalcemia and hungry bone syndrome remain common. Vitamin D deficiency has been suggested as a modifiable risk factor, but evidence supporting preoperative supplementation is inconsistent.
Matthew Gynn +2 more
wiley +1 more source
Nephrolithiasis-induced end stage renal disease
, 2010 M Ounissi¹, T Gargueh², M Mahfoudhi¹, K Boubaker¹, H Hedri¹, R Goucha¹, E Abderrahim¹, F Ben Hamida¹, T Ben Abdallah¹, F El Younsi¹, H Ben Maiz³, A Kheder ...
M Mahfoudhi, M Ounissi, et al, T Gargueh
core
Potential metabolic pathways of nephrolithiasis mediated by occupational cadmium exposure
环境与职业医学BackgroundLong-term cadmium exposure is a risk factor for nephrolithiasis; however, the mechanisms underlying cadmium-mediated nephrolithiasis remain unclear.ObjectiveTo investigate the potential metabolic pathways involved in nephrolithiasis induced by ...
Yaotang DENG +9 more
doaj +1 more source